Bioanalytical Method Development and Validation
Bioanalytical Method Development and Validation for Small Organic Molecules, Active Ingredients, Metabolites and large peptides and proteins in complex biological fluids. We use the state of the art instrumentation and the most advanced techniques for Bioanalytical method development and method validation:
- LCMS, LC/MS/MS
- GCMS, GC/MS/MS
- Bioanalytical method
- Automated solid phase extraction
- Automated liquid-liquid extraction
- ELISA
- Method Development for Drug Substance in Biological Matrix
- Method Validation for Phase II and Phase III Clinical Trails
- Method Development and Validation for Metabolites
- Metabolite Identification using High Resolution Mass Spectrometry
- Pharmacokinetics Studies
- Method Development and Validation for Proteins and Peptides
- Method Development for Drug Substance in Cells
- Method Development for Phase I, Phase II, and Phase III clinical trials
- Method Development for various analytes and their metabolites in serum, plasma, blood, urine, saliva, cerebral spinal fluid, and biological tissues
